EXHIBIT 23.2
Published on March 31, 2006
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the Registration Statement of
Rexahn Pharmaceuticals, Inc. on Form S-8 (Registration Statement No. 333-129294)
of our report dated February 25, 2005 (which report expresses an unqualified
opinion), relating to the financial statements of Rexahn Pharmaceuticals,
Inc.
(formerly Rexahn, Corp) included in the Annual Report on Form 10-KSB of Rexahn
Pharmaceuticals, Inc. for the fiscal year ended December 31, 2005.
/s/
SF
Partnership, LLP
Chartered
Accountants
Toronto,
Canada
March
31,
2006